Investors are debating whether the jobs market’s resilience will prompt worrisomely tight Fed policy or is a sign that the economy can skirt a recession.…
By Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD's Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic…
Reallocate costs. Unwind charges. Delay depreciation. Companies are using nontraditional ways to boost the bottom line as slowing business makes it harder to meet earnings…
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.…
The nation’s post-Covid recovery, which handily outperformed economists’ expectations in early 2023, lost momentum this spring. Read the original article
MarketsHeard on the StreetGenerative AI, banking troubles and a volatile world economy are giving investors reasons to crowd into bigger companies Read the original article